Paper: Predictive Markers of High-Grade or Serious Treatment-Emergent Infections with Daratumumab-Based Regimens in Newly Diagnosed Multiple Myeloma (NDMM)

Oral and Poster Abstracts 653. Myeloma/Amyloidosis: Therapy, excluding Transplantation: Poster III Adult, Biological, multiple myeloma, antibodies, Diseases, Therapies, Plasma Cell Disorders, Study Population, Lymphoid Malignancies Niels W.C.J. Van De Donk1, Sonja Zweegman, MD, PhD2, Jesus F. San-Miguel, MD, PhD3, Meletios A Dimopoulos4, Michele Cavo5*, Kenshi Suzuki, MD, PhD6,…

Read the full article here

Source: ash.confex.com
Categories: Hem/Oncs, Latest Headlines
Tags: , ,
Tweets with this article
Mike Thompson, MD, PhD, FASCO
Predictive Markers of High-Grade or Serious Tx-Emergent Infections w/ Daratumumab-Based Regimens in NDMM - Van De Donk et al. #ASH20 Abs 3209 https://t.co/E2Jv6ChZMz #mmsm #IDonc The final (MVA) predictive model included age, LDH, albumin & elevated baseline ALT levels (Table) https://t.co/w6TZz4xXgB
Mike Thompson, MD, PhD, FASCO
Predictive Markers of High-Grade or Serious Tx-Emergent Infections w/ Daratumumab-Based Regimens in NDMM - Van De Donk et al. #ASH20 Abs 3209 https://t.co/E2Jv6ChZMz #mmsm #IDonc Most common SAE _or_ grade 3/4 infection was pneumonia in ALCYONE (D-VMP vs VMP) & MAIA (D-Rd vs Rd)
Mike Thompson, MD, PhD, FASCO
Predictive Markers of High-Grade or Serious Treatment-Emergent Infections with Daratumumab-Based Regimens in Newly Diagnosed Multiple Myeloma (NDMM) - Niels W.C.J. Van De Donk et al. #ASH20 Abstract 3209 Mon, Dec 7, 2020, 7:00 AM-3:30 PM https://t.co/E2Jv6ChZMz #mmsm #IDonc https://t.co/JBAc8qKdNV

Related Articles